• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活型免疫受体NKG2D及其MHC I类样配体MICA的复杂结构

Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA.

作者信息

Li P, Morris D L, Willcox B E, Steinle A, Spies T, Strong R K

机构信息

Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 USA.

出版信息

Nat Immunol. 2001 May;2(5):443-51. doi: 10.1038/87757.

DOI:10.1038/87757
PMID:11323699
Abstract

The major histocompatibility complex (MHC) class I homolog, MICA, is a stress-inducible ligand for NKG2D, a C-type lectin-like activating immunoreceptor. The crystal structure of this ligand-receptor complex that we report here reveals an NKG2D homodimer bound to a MICA monomer in an interaction that is analogous to that seen in T cell receptor-MHC class I protein complexes. Similar surfaces on each NKG2D monomer interact with different surfaces on either the alpha1 or alpha2 domains of MICA. The binding interactions are large in area and highly complementary. The central section of the alpha2-domain helix, disordered in the structure of MICA alone, is ordered in the complex and forms part of the NKG2D interface. The extensive flexibility of the interdomain linker of MICA is shown by its altered conformation when crystallized alone or in complex with NKG2D.

摘要

主要组织相容性复合体(MHC)I类同源物MICA是NKG2D的应激诱导配体,NKG2D是一种C型凝集素样激活免疫受体。我们在此报道的这种配体-受体复合物的晶体结构揭示了一个NKG2D同二聚体与一个MICA单体结合,其相互作用类似于在T细胞受体-MHC I类蛋白复合物中看到的相互作用。每个NKG2D单体上的相似表面与MICA的α1或α2结构域上的不同表面相互作用。结合相互作用面积大且高度互补。单独的MICA结构中无序的α2结构域螺旋的中央部分在复合物中是有序的,并形成NKG2D界面的一部分。MICA结构域间连接子的广泛灵活性通过其单独结晶或与NKG2D复合结晶时构象的改变得以体现。

相似文献

1
Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA.激活型免疫受体NKG2D及其MHC I类样配体MICA的复杂结构
Nat Immunol. 2001 May;2(5):443-51. doi: 10.1038/87757.
2
Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A.小鼠自然杀伤细胞激活受体NKG2D在1.95埃分辨率下的晶体结构。
Nat Immunol. 2001 Mar;2(3):248-54. doi: 10.1038/85311.
3
NKG2D and Related Immunoreceptors.自然杀伤细胞2D及相关免疫受体
Adv Protein Chem. 2004;68:281-312. doi: 10.1016/S0065-3233(04)68008-9.
4
The inhibitory effects of synthetic short peptides, mimicking MICA and targeting at NKG2D receptors, on function of NK cells.模拟MICA并靶向NKG2D受体的合成短肽对自然杀伤细胞功能的抑制作用。
Peptides. 2005 Mar;26(3):405-12. doi: 10.1016/j.peptides.2004.10.008.
5
Natural killer cell recognition of HLA class I molecules.自然杀伤细胞对HLA I类分子的识别。
Rev Immunogenet. 2000;2(3):433-48.
6
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.不同组织类型肿瘤细胞系上主要组织相容性复合体I类相关链A和UL16结合蛋白的表达:肿瘤对NKG2D依赖性自然杀伤细胞细胞毒性的易感性分析
Cancer Res. 2002 Nov 1;62(21):6178-86.
7
A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.一种新型的NKG2D受体配体可激活自然杀伤细胞和巨噬细胞并诱导肿瘤免疫。
Eur J Immunol. 2003 Feb;33(2):381-91. doi: 10.1002/immu.200310012.
8
Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.二硫键异构酶促进肿瘤相关NKG2D配体的脱落
Nature. 2007 May 24;447(7143):482-6. doi: 10.1038/nature05768. Epub 2007 May 9.
9
The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.抑制性自然杀伤细胞受体CD94/NKG2A和激活性受体CD94/NKG2C通过大部分共享但部分不同的HLA-E残基集合与HLA-E的顶部结合。
Eur J Immunol. 2004 Jan;34(1):81-90. doi: 10.1002/eji.200324432.
10
Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.应激诱导蛋白ULBP和MICA的细胞表面组织,其通过NKG2D刺激人自然杀伤细胞和T细胞。
J Exp Med. 2004 Apr 5;199(7):1005-10. doi: 10.1084/jem.20032194. Epub 2004 Mar 29.

引用本文的文献

1
The Role of MICA/B Molecules and the NKG2D Receptor in the Interaction Between NK-92 Cells and JEG-3 Cells.MICA/B分子和NKG2D受体在NK-92细胞与JEG-3细胞相互作用中的作用
Int J Mol Sci. 2025 Aug 29;26(17):8400. doi: 10.3390/ijms26178400.
2
Defining the genetic determinants of CD8 T cell receptor repertoire in the context of immune checkpoint blockade.在免疫检查点阻断的背景下定义CD8 T细胞受体库的遗传决定因素。
Sci Adv. 2025 Jul 25;11(30):eadu3461. doi: 10.1126/sciadv.adu3461.
3
Tandem CAR T-cells targeting CD19 and NKG2DL can overcome CD19 antigen escape in B-ALL.
靶向CD19和自然杀伤细胞激活配体(NKG2DL)的串联嵌合抗原受体(CAR)T细胞可克服B细胞急性淋巴细胞白血病(B-ALL)中的CD19抗原逃逸。
Front Immunol. 2025 May 9;16:1557405. doi: 10.3389/fimmu.2025.1557405. eCollection 2025.
4
Recognition of Self and Viral Ligands by NK Cell Receptors.自然杀伤细胞受体对自身和病毒配体的识别。
Immunol Rev. 2025 Jan;329(1):e13435. doi: 10.1111/imr.13435.
5
Agonistic anti-NKG2D antibody structure reveals unique stoichiometry and epitope compared to natural ligands.激动型抗 NKG2D 抗体结构与天然配体相比具有独特的计量比和表位。
MAbs. 2024 Jan-Dec;16(1):2433121. doi: 10.1080/19420862.2024.2433121. Epub 2024 Nov 25.
6
Direct recognition of an intact foreign protein by an αβ T cell receptor.αβ T 细胞受体对完整外来蛋白的直接识别。
Nat Commun. 2024 Oct 11;15(1):8816. doi: 10.1038/s41467-024-51897-3.
7
CAR-T cell therapy: Advances in digestive system malignant tumors.嵌合抗原受体T细胞疗法:消化系统恶性肿瘤的研究进展
Mol Ther Oncol. 2024 Sep 10;32(4):200872. doi: 10.1016/j.omton.2024.200872. eCollection 2024 Dec 19.
8
The activating receptor NKG2D is an anti-fungal pattern recognition receptor.激活受体 NKG2D 是一种抗真菌模式识别受体。
Nat Commun. 2024 Oct 7;15(1):8664. doi: 10.1038/s41467-024-52913-2.
9
Combined Physics- and Machine-Learning-Based Method to Identify Druggable Binding Sites Using SILCS-Hotspots.基于物理和机器学习的联合方法,利用 SILCS-Hotspots 识别可成药结合位点。
J Chem Inf Model. 2024 Oct 14;64(19):7743-7757. doi: 10.1021/acs.jcim.4c01189. Epub 2024 Sep 16.
10
The HHV-6B U20 glycoprotein binds ULBP1, masking it from recognition by NKG2D and interfering with natural killer cell activation.HHV-6B U20 糖蛋白结合 ULBP1,使其逃避 NKG2D 的识别,从而干扰自然杀伤细胞的激活。
Front Immunol. 2024 Jun 17;15:1363156. doi: 10.3389/fimmu.2024.1363156. eCollection 2024.